Model-Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing.

Journal: Clinical pharmacology and therapeutics
Published Date:

Abstract

The availability of multidimensional data together with the development of modern techniques for data analysis represent an exceptional opportunity for clinical pharmacology. Data science-defined in this special issue as the novel approaches to the collection, aggregation, and analysis of data-can significantly contribute to characterize drug-response variability at the individual level, thus enabling clinical pharmacology to become a critical contributor to personalized healthcare through precision dosing. We propose a minireview of methodologies for achieving precision dosing with a focus on an artificial intelligence technique called reinforcement learning, which is currently used for individualizing dosing regimen in patients with life-threatening diseases. We highlight the interplay of such techniques with conventional pharmacokinetic/pharmacodynamic approaches and discuss applicability in drug research and early development.

Authors

  • Benjamin Ribba
    Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Sherri Dudal
    F. Hoffmann La Roche Ltd., Basel, Switzerland.
  • Thierry LavĂ©
    F. Hoffmann La Roche Ltd., Basel, Switzerland.
  • Richard W Peck
    F. Hoffmann La Roche Ltd., Basel, Switzerland.